Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88323973 |
LAW OFFICE ASSIGNED |
LAW OFFICE 101 |
MARK SECTION |
MARK |
TIOCYSTIN (see, http://uspto.report/TM/88323973/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
TIOCYSTIN |
OWNER SECTION (current) |
NAME |
CASPER PHARMA LLC |
STREET |
2 TOWER CENTER BOULEVARD, SUITE 1101C |
CITY |
EAST BRUNSWICK |
STATE |
New Jersey |
ZIP/POSTAL CODE |
08816 |
COUNTRY |
United States |
PHONE |
732-243-0042 |
FAX |
732-227-1513 |
EMAIL |
XXXX |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
OWNER SECTION (proposed) |
NAME |
CASPER PHARMA LLC |
INTERNAL ADDRESS |
2 TOWER CENTER BOULEVARD, SUITE 1101C |
STREET |
2 TOWER CENTER BOULEVARD, SUITE 1101C |
CITY |
EAST BRUNSWICK |
STATE |
New Jersey |
ZIP/POSTAL CODE |
08816 |
COUNTRY |
United States |
PHONE |
9176012 |
FAX |
732-227-1513 |
EMAIL |
XXXX |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparation for the prevention of cystine kidney stone formation |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
1 |
ALLOWANCE MAIL DATE |
08/20/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/Edward Neugeboren/ |
SIGNATORY'S NAME |
Edward Neugeboren |
SIGNATORY'S POSITION |
Chief Strategy Officer |
DATE SIGNED |
12/03/2019 |
SIGNATORY'S PHONE NUMBER |
7322438471 |
FILING INFORMATION |
SUBMIT DATE |
Tue Dec 03 11:26:20 EST 2019 |
TEAS STAMP |
USPTO/ESU-XX.XXX.XX.XXX-2
0191203112620251654-88323
973-70047a7a8318d148c6344
b7781753bc6335e5e1d735b96
d88b46964a13bf1564d-CC-26
180978-201911251452266454
98 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: TIOCYSTIN (see, http://uspto.report/TM/88323973/mark.png)
SERIAL NUMBER: 88323973
The applicant, CASPER PHARMA LLC, having an address of
2 TOWER CENTER BOULEVARD, SUITE 1101C
2 TOWER CENTER BOULEVARD, SUITE 1101C
EAST BRUNSWICK, New Jersey 08816
United States
9176012
732-227-1513
XXXX (authorized)
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 08/20/2019.
For International Class 005:
Current identification: Pharmaceutical preparation for the prevention of cystine kidney stone formation
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the first extension request.
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /Edward Neugeboren/ Date Signed: 12/03/2019
Signatory's Name: Edward Neugeboren
Signatory's Position: Chief Strategy Officer
Signatory's Phone: 7322438471
RAM Sale Number: 88323973
RAM Accounting Date: 12/03/2019
Serial Number: 88323973
Internet Transmission Date: Tue Dec 03 11:26:20 EST 2019
TEAS Stamp: USPTO/ESU-XX.XXX.XX.XXX-2019120311262025
1654-88323973-70047a7a8318d148c6344b7781
753bc6335e5e1d735b96d88b46964a13bf1564d-
CC-26180978-20191125145226645498